Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cannabis producer Tilray to buy rival HEXO's debt of up to $211 million

Published 03/03/2022, 08:51 AM
Updated 03/03/2022, 08:55 AM
© Reuters. FILE PHOTO: A Hexo Corp logo is pictured behind cannabis plants at their facilities in Gatineau, Quebec, Canada, September 26, 2018. REUTERS/Chris Wattie/

(Reuters) - Tilray (NASDAQ:TLRY) Brands on Thursday agreed to buy up to $211 million of HEXO (NASDAQ:HEXO)'s debt, giving the Canadian cannabis producer a right to pick a significant equity stake in its troubled rival.

The deal gives HEXO more favourable debt repayment terms, potentially rescuing the company from years-long financial turmoil.

U.S-listed shares in HEXO were about 17% higher in pre-market trading.

"HEXO has endured a crippling overhang for the past twelve months, due to punitive redemptions and discounted dilutive financings, and we needed to solve this issue in order to make positive progress," said Mark Attanasio, chair of the HEXO's board.

Last year, HEXO disclosed its ongoing concern with its senior secured convertible notes issued on May 27 and noted it may not have enough cash coming in to help pay off the debt.

The latest deal provides Tilray with about C$20 million in interest payments in the first year, adding about 4 cents per share to future earnings, and C$50 million of cost savings, to be shared equally with HEXO, within two years of the completion of the deal.

The notes, which would be purchased by Tilray from current debt holder HT Investments MA LLC, would be amended to permit Tilray to exercise conversion rights at a price of C$0.90 per HEXO share and acquire a significant equity ownership position in HEXO in the future.

Last month, HEXO said it would refresh its board, effective immediately, as part of a deal with activist shareholder Adam Arviv and his fund, Kaos Capital, over concerns over its sliding share price.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.